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Title: Can mammogram-readers swiftly and effectively learn to interpret First post contrast 
Acquisition SubtracTed (FAST) MRI, a type of abbreviated breast MRI? - A single centre data-
interpretation study 
Running title: Abbreviated breast MRI (FAST MRI) interpretation 
Key words: Breast cancer; screening; early diagnosis; imaging biomarker; abbreviated breast 
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Abbreviations:  
FAST MRI First postcontrast Acquisition SubTracted breast Magnetic Resonance 
Imaging (a type of abbreviated breast MRI) 
MR or MRI Magnetic Resonance Imaging 
MIP Maximum Intensity Projection image of combined stack of subtracted slices 
NHS  National Health Service 
NHSBSP National Health Service Breast Screening Programme 
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Abstract 
Objectives: To assess whether NHS breast screening programme (NHSBSP) mammogram 
readers could effectively interpret First post contrast Acquisition SubTracted (FAST) MRI, for 
intended use in screening for breast cancer. 
Methods: Eight NHSBSP mammogram readers from a single centre (4 who also read breast 
MRI (Group 1) and 4 who do not (Group 2)) were given structured FAST-MRI reader training 
(median 4 hours: 32 minutes). They then prospectively interpreted 125 FAST MRIs (250 
breasts: 194 normal and 56 cancer) comprising a consecutive series of screening MRIs 
enriched with additional cancer cases from 2015, providing 2000 interpretations. Readers 
were blinded to other readers’ opinions and to clinical information. Categorisation followed 
the NHSBSP MRI reporting categorisation, with categories 4 and 5 considered indicative of 
cancer. Diagnostic accuracy (reference standard: histology or 2 years’ follow up) and 
agreement between readers were determined. 
Results: The accuracy achieved by Group 2 (847/1000 (85%; 95% confidence interval (CI) 82-
87%)) was 5% less than that achieved by Group 1 (898/1000 (90%; 95% CI 88-92)). Good 
inter-reader agreement was seen between both Group 1 readers (kappa=0.66; 95% CI 0.61-
0.71) and Group 2 readers (kappa=0.63; 95% CI 0.58-0.68). The median time taken to 
interpret each abbreviated MRI was Group 1: 34 seconds (range 3-351) and Group 2: 77 
(range 11-321). 
Conclusion: Brief structured training enabled multi-professional mammogram readers to 
achieve similar accuracy at FAST MRI interpretation to consultant radiologists experienced 
at breast MRI interpretation.  
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Advances in knowledge: FAST MRI could be feasible from a training-the-workforce 
perspective for screening within NHSBSP. 
 
Key Words: Breast cancer, Early diagnosis, Screening, Abbreviated breast MRI, Imaging 
biomarker, Training 
Introduction 
Mammographic screening programmes result in both over-diagnosis and under-diagnosis of 
breast cancer(1–3) . Under-diagnosis leads to cancers presenting symptomatically between 
screening visits (interval cancers), and to continued presentation of Stage 2 or greater 
breast cancers(4). Although magnetic resonance imaging (MRI) is the most sensitive method 
to detect breast cancer, currently only women classified as high risk (>30% lifetime risk) are 
offered screening MRI in the UK(5). However, in the future, personalised screening could 
enable larger numbers of women to be offered different screening regimes, each 
incorporating different imaging modalities, according to their level of risk(6,7).  
 
Finding breast cancer early saves lives(8,9), and there is therefore a need to develop cost-
effective imaging tests that will benefit women at risk of breast cancer by finding significant 
disease early(10). First post contrast Acquisition SubTracted (FAST) MRI is a type of 
abbreviated breast MRI and has been suggested as such a screening test since proof of 
concept studies suggest it could offer accuracy of breast cancer detection almost equivalent 
to full protocol breast MRI with speed of acquisition and reporting that approaches that of 
mammography (11–13). This technique might especially benefit women with dense breasts 
since cancers obscured by dense tissue on mammograms are often visible on MRI(14). 
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Mammographic population screening for breast cancer necessitates a high volume of 
throughput of images for interpretation, and in many countries radiologists who interpret 
mammograms do not necessarily also interpret breast MRI, a less frequently performed and 
more complex modality. In the UK, skills-mix has enabled professionals other than 
radiologists, including advanced practitioner radiographers, to learn to interpret screening 
mammograms and studies demonstrate their adequacy of performance at this task(15,16). 
The present study is the first to look at the capability of mammogram readers in the context 
of FAST MRI interpretation. FAST MRI was the new technology chosen for this study because 
it is the MR sequence common to most reported types of abbreviated protocol, with the 
shortest reported interpretation time and simplest format(11). In the design of this study, 
the authors postulated that its simplicity and the similarities of display between it and 
mammographic modalities would be likely to enable mammogram readers to easily and 
quickly learn FAST MRI interpretation.  In the current study we chose to further simplify the 
display protocol, and unlike in Kuhl’s original description of FAST MRI(11), the unsubtracted 
images were not made available for interpretation by our readers. This simplification of the 
display protocol was intended to ease training of mammogram readers, unfamiliar with 
multiple sequences.  
 
The aim of this study was to explore whether NHSBSP mammogram readers can learn to 
effectively interpret FAST MRI with less than one day’s additional training, and to match the 
capabilities of expert breast MRI readers at this task in terms of accuracy and speed of 
interpretation.  
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Methods and Materials 
Research Ethics Committee and Health Research Authority approval were obtained 
(references: REC 17/SW/0142, IRAS 219332). Informed consent was obtained from all study 
participants. 
Study design 
Prospective, blinded interpretation by multiple readers of an enriched dataset with known 
outcome. 
 
Test set of Images 
A set of FAST MRI examinations was created by copying and reducing (post-processing) 
breast MRI scans that were acquired at a single centre during 2015. MRIs were acquired 
exclusively during a single year in order to standardise scan quality. A consecutive sample of 
all breast MRIs  performed as screening for women at high risk of breast cancer according to 
NICE guidelines (>30% lifetime risk from the age of 20 years) (5)  were included (72 MRIs). 
These were enriched with 54 symptomatic MRIs including 1 with bilateral cancer and 53 
with unilateral cancer (Figure 1). Two of the screening MRIs also showed a unilateral cancer. 
The clinical indications given for the 125 MRI scans that were included in the dataset are 
shown in Table 1. In order to increase task difficulty, only cancers smaller than 25mm were 
included, as measured on the original full MRI report. All cancer cases were confirmed by 
histological analysis of breast tissue. The histology of the 56 cancers in the dataset is shown 
in Table 2.  Breasts were classified as not having cancer through either negative 
interpretation of full MRI by at least one fully trained radiologist or uncertain interpretation 
of full MRI and negative ultrasound (+/- biopsy), and at least 2 years’ follow up data without 
cancer.  
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The median age of the women imaged was 40 years (range 28-61) in the high-risk screening 
population and 58 (35-83) for the women with a new cancer diagnosis. 
 
Breast MRI protocol 
All MRI examinations in the dataset were originally acquired on either a Philips (Amsterdam, 
Netherlands) Ingenia 1.5T or a Philips Ingenia 3T scanner. The breast coils used were 
dStream Breast 7 channel coils. The paramagnetic contrast agent used was gadobutrol 
1.0mmol/ml and the dose administered was 0.1 millilitre gadobutrol per kg body weight (for 
example, a patient weighing 70kg would require a dose of 7 millilitres). The dynamic 
sequence used (from which the dataset’s FAST MRI images were obtained through post-
processing) was dyn_eTHRIVE (Axial 3D T1 fast field echo (FFE)). Since the images used in 
the current study were originally acquired in 2015 and then later reprocessed and 
anonymised for the study, the acquisition protocol conformed to our own centre’s standard. 
This differed from Kuhl’s description of FAST MRI(11) as follows:  
 The breasts were not compressed during MR acquisition.  
 The T1 images of the dynamic study that were used to form the subtracted images 
were fat-suppressed (dyn_eTHRIVE). 
The MRI scans performed for a screening indication were performed during day 6-16 of the 
woman’s menstrual cycle, but those performed post cancer diagnosis were performed 
promptly without reference to the woman’s menstrual cycle. 
 
The MRI studies were copied, anonymised and allocated study identifiers chronologically for 
the date they were acquired, and as a consequence normal and abnormal scans were 
presented to the readers in an unpredictable order. They were then reduced to comprise 
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simply those MR sequences that would have been obtained if they had originally been 
acquired as a FAST MRI, displayed as an axial maximum intensity projection image (MIP), 
and also as a stack of axial slices (slice stack) of the first post contrast subtracted images 
from the dynamic series of the breast MRI examination(11). This process was performed by 
two of the research team who were not subsequently part of either of the two reading 







Eight radiology practitioners from a single centre were recruited as image readers; all 
practised as NHSBSP mammogram readers. These 8 practitioners comprised 4 readers who 
also practised as NHSBSP breast MRI readers (Group 1) and 4 readers who did not read 
breast MRI in their normal clinical practice (Group 2). Group 1 were all consultant 
radiologists with between 4 and 11 years’ experience of reading both mammograms and 
breast MRIs. Individual members of Group 1 read between 5000 and 6,500 mammograms 
and between 100 and 225 breast MRIs each year. Group 2 comprised a consultant 
radiologist, a consultant radiographer and two film reading radiographers, with individual 
experience of reading mammograms ranging from 2 to 28 years and each member of Group 
2 read between 5000 and 18,000 mammograms each year.  
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Standardised Training 
All 8 readers were trained to read FAST MRI using a structured training package (17) 
including one-to-one training and interactive small group presentation components. All 
readers were then offered an additional one-to-one teaching session if they felt they would 
benefit. The examples of FAST MRI shown to the readers during the training were not from 
the subsequently interpreted dataset. 
 
The structured training delivered during the present study to all-but-one reader took half a 
day to deliver. One reader (Reader Identifier 2.2) requested further training and this was 
delivered as a second one-to-one session, lasting one hour, when the reading task was four 
fifths completed. 
 
Once trained, each reader completed a data-form for each FAST MRI case within the 
dataset, blinded to the identity of the patient, clinical history, original full MRI, all other 
imaging including mammograms, ultrasounds and previous breast MRI examinations, the 
outcome (cancer or no cancer) and to the opinions and completed data forms of the other 
readers. The FAST MRI case studies were read in batches of up to 25 because the 
workstation that displayed the images had a limited capacity for data-storage and was also 
required for routine clinical work.  
 
Classification system 
The readers were instructed to classify each breast of each FAST MRI examination in 
accordance with a modified version of the MRI screening reporting categories of 
classification outlined in the 2012 NHSBSP guidelines for screening higher risk women, 
where MRI1 and MRI2 indicate normal and benign, MRI3 indicates an indeterminate 
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classification, and MRI4 and MRI5 indicate suspicious and definitely malignant appearances 
respectively(18). The recommended MRI screening reporting categories were modified 
because FAST MRI differs from the full diagnostic protocol in providing limited 
morphological information and only a single time-point from the dynamic scan.  
 
Statistical Analysis 
A per breast analysis of the frequency of MRI classifications against the true outcome was 
obtained overall and for each reader. The overall accuracy, sensitivity, specificity, false 
positive and negative rates (with total reads as denominator) and the positive and negative 
predictive values of the readers’ MRI classification with the true outcome were calculated. 
Differences in accuracy, sensitivity and specificity across reader groups were analysed using 
a multilevel generalised mixed model to account for multiple readers per case. The inter-
reader variability and the agreement between readers and the true outcome was assessed 
using Cohen’s kappa coefficient to account for the probability of the agreement occurring by 
chance. A kappa statistic value of greater than 0.60 would represent good agreement. An 
MRI classification of 4 and 5 was considered indicative of cancer, and classifications of 1-3 
considered a normal result. A sensitivity analysis was performed whereby those with an 
indeterminate classification MRI 3 were classified as cancer. The FAST MRI interpretation 
times were compared across reader groups using a Wilcoxon signed rank test and the 
reader training times compared using a Wilcoxon rank sum test. 
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Results 
All 8 readers completed the reading task of 125 cases (250 breasts). Per breast analysis 
comparing the readers’ MRI classification with the true outcome (cancer or normal) showed 
an overall concordance with the true outcome of 87% (95% confidence interval (CI) 86-89%; 
1745/2000 reads), with 393 (88%) cancers correctly identified and 1352 (87%) normal 
results correctly identified (Table 3). The overall sensitivity was 88% (95% CI 84-91%) and 
specificity 87% (95% CI 85-89%) (Table 4). The agreement between all readers and the true 
outcome demonstrated good concordance with a kappa of 0.69 (95% CI 0.65-0.72).  
 
The concordance with the true outcome achieved by Group 2 (847/1000 (85%; 95% CI 82-
87%)) was 5% less than that achieved by Group 1 (898/1000 (90%; 88-92%)) (Table 5), a 
small but significant difference (p<0.0001). Results for readers in Group 2 showed a non-
significant trend towards higher sensitivity (89%; 95% CI 85-93%) but significantly lower 
specificity (83%; 95% CI 81-86%) than for readers in Group 1 (sensitivity 86%; 95% CI 81-
90%, p=0.23; specificity 91%; 95% CI 89-93%, p<0.0001). Good inter-reader agreement was 
observed between the Group 1 readers (kappa=0.66; 95% CI 0.61-0.71) and also between 
the Group 2 readers (kappa=0.63; 95% CI 0.58-0.68) (Table 5). 
 
A sensitivity analysis considering MRI classifications 3, 4 and 5 to indicate cancer gave an 
overall accuracy of 78% (1550/2000; 95% CI 76-79%; Table 4).  
Time taken to report 
The time taken for the individual readers to interpret each FAST MRI examination was 
significantly less for Group 1 (median 34 seconds, range 3-351 seconds) than for Group 2 (77 
seconds, 11-321 seconds, p <0.0001).  
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Time taken to train 
It took less than one day of structured training to train the readers in this study. The training 
time between groups was not significantly different (median training time 4:01 
(hours:minutes) and range 3:25–4:42) for Group 1, and 4:55 (4:25-6:04) for Group 2, 
p=0.11). 
Discussion 
Following less than one day’s structured training the NHSBSP mammogram readers in this 
study achieved a good agreement between their interpretation of FAST MRI and the 
clinically proven outcome in this enriched dataset. The group with no previous experience of 
breast MRI performed just 5% less well in terms of overall accuracy in comparison with the 
group of expert breast MRI readers. Looking at the individual accuracy for the readers 
within each group (Table 4), there is some overlap between groups: the lowest accuracy in 
Group 1 of 86% is lower than the accuracy of the two best performing readers in Group 2.  
 
The median time taken to interpret FAST MRI by individual readers in Group 1 ranged from 
27-44 seconds with a median for the whole group of 33 seconds. This is similar to the 28 
seconds taken by expert readers in Kuhl’s original proof of concept publication(11). For 
Group 2 the range was 57-144 with a median for the whole group of 77 seconds, double 
that of Group 1. This significant difference between groups may indicate that following 
training, new readers of FAST MRI may take time to achieve the same reading speed as 
experienced MRI readers.  
 
A UK workplace-based double module in breast MRI reporting, as part of an MSc in Clinical 
Reporting for Radiographers and Breast Clinicians, has recently been established, designed 
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for professionals already competent in both mammogram interpretation and breast 
ultrasound performance. It includes a logbook of 200 breast MRI examinations reported by 
the trainee and requires a radiologist to mentor each participant during the 9 month course. 
This course successfully achieves acceptable competency levels(19), but the complexity and 
length of the course make it impractical for training the whole image-reading workforce, for 
both manpower and financial reasons. In contrast, the interpretation of digital breast 
tomosynthesis can be effectively learnt by a professional competent at mammogram 
interpretation, within a single structured day of study(20).  
 
 
Interestingly, the readers in this study achieved a better match in terms of overall accuracy 
when MRI 4 and 5 were taken to indicate cancer and MRI 1,2 and 3 to indicate normal than 
if MRI 3 were to be included with 4 and 5 to indicate cancer. This is unsurprising because the 
use of the “3” category by a reader indicates that the reader is uncertain whether or not a 
cancer is present. It has previously been reported that in mammogram reporting 10-30% of 
breasts classified as “3” demonstrate a true cancer(21,22), and our study’s results fall within 
that range; of the 247 “3” classifications given by our readers, only 26 (11%) were cancers. 
Mammographic screening programmes recall “3” classifications for further imaging. This is 
necessary because mammographic techniques selectively pick up low-grade, biologically 
indolent cancers(23,24) so that choosing to ignore indeterminate abnormalities in 
mammographic screening is risky because small, high-grade, biologically aggressive cancers 
can have a subtle or indeterminate appearance on mammogram(25). In contrast, FAST MRI 
was originally designed to preferentially pick up the biologically aggressive cancers(11,26), 
and so choosing not to recall indeterminate findings from screening moderate risk women 
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with FAST MRI might be less risky because aggressive cancers would be clearly seen as 
cancer. Whilst choosing to screen with FAST MRI rather than mammograms has the primary 
objective of reducing under-diagnosis, choosing not to recall indeterminate (“3”) FAST MRI 
findings might have the additional benefits of reducing both overdiagnosis and false positive 
recall rate(26). Reducing the number of screening assessments by reducing the number of 
women with normal breasts incorrectly recalled from screening would also reduce cost to 
the NHS.  
 
Limitations of the study include that it uses an enriched dataset and not a real-life data 
series of screening cases, and therefore comparison of our results with those of screening 
studies is spurious. The creators of any enriched dataset determine its degree of difficulty, 
and therefore comparisons between readers of differently created datasets can be 
meaningless. As a consequence of the selection of cancers in our dataset being dependent 
on the indications for breast MRI at our institution, there were a very high proportion of 
lobular cancers included in our dataset (25/56 = 45%). This bias in our selection of cancer 
cases and our choice to limit the size of the included cancers increased the difficulty of the 
test we set our readers. In opposition to this effect, we chose not to include MRIs 
performed following a known cancer diagnosis that had originally been reported as MRI 1,2 
or 3. This excluded cases that were occult on full protocol MRI, but since only 5 scans were 
excluded for this reason (Figure 1) the effect on reader results is not likely to be marked. In 
the UK both MRI and mammograms performed for breast screening are double-read, but in 
this study the dataset of FAST MRIs was single read, without access to previous 
examinations.  
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Overall, we believe that the enriched data-set of FAST MRI images developed during this 
study is an effective and challenging test of performance at FAST MRI interpretation, and 
that the performance of readers when reading this dataset is likely to be an underestimate 
of their potential performance in screening practice, and may also be an underestimate of 
the difference between groups.  
 
It may be considered a further limitation that the dataset of FAST MRI was acquired on a 
mixture of 1.5T and 3T scanners though this mixture of available equipment does reflect 
real life practice within NHSBSP, and a strength of this study is that both this mixture of 
scanners used and the mixture of multiprofessional readers that participated in the study 
represent the full range of scanners and of mammogram readers within NHSBSP at our 
centre. 
 
The results of this study suggest that training mammogram readers to interpret FAST MRI 
may not take long, but allowance for longer interpretation times should be factored into 
workforce planning whilst they adapt to the new technology. Questions for future research 
include whether readers new to the technology can, with experience or additional training, 
speed up to the level achieved by expert MRI readers and how much additional experience 
or training is required to achieve adequate parity of performance.   




Overall, the results of this study, of a small sample of image readers, suggest that brief 
training of the whole NHSBSP image-reading workforce is likely to be sufficient to enable 
effective interpretation of FAST MRI in terms of accuracy and speed of interpretation. 
 
Further studies, increasing the number of study participants (readers) and lengthening the 
training to a whole day of interactive teaching, are necessary to decide whether the 
difference between the groups can be further reduced and the overall accuracy  and 
interpretation speed further improved prior to subsequent prospective studies of FAST MRI 
in a real-world screening setting. 
 
 A prospective study in real life screening practice is needed to determine whether choosing 
only to recall suspicious or malignant-appearing cases (MRI 4&5) on FAST MRI could be an 
effective strategy rather than the current standard of additionally recalling MRI 3 found on 
mammograms. 
 
Additional information (not included in word count) 
Consent for publication 
Consent for publication of the MRI images included in this article has been obtained from 
the patients imaged. 
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Figure and Table Legends 
Figure 1: Flow diagram to illustrate FAST MRI dataset 
 
Figure 2: MRI classifications of each of the 250 breasts by the 8 image readers  
Figure 2a: 56 breasts with cancer 
Figure 2b: 194 normal breasts 
 
Figure 3: Examples of FAST MRI images of breasts with cancer from the dataset  
Figure 3a: FAST MRI axial MIP image showing a Grade 3 invasive breast cancer (blue 
arrow) as an enhancing mass correctly classified as MRI 4 or 5 by 8/8 image readers. 
The original clinical indication for breast MRI was “palpable cancer not visible 
(occult) on mammogram” 
Figure 3b: FAST MRI axial MIP image showing High Grade ductal carcinoma in situ 
(DCIS) as asymmetric non-mass enhancement (blue arrows) correctly classified as 
MRI 4 or 5 by 7/8 image readers. This image also illustrates that the heart (paired 
arrows) and blood vessels exhibit enhancement on FAST MRI. 
Figure 3c: FAST MRI axial slice from slice stack showing a lobular carcinoma (blue 
arrow) that showed only on this single slice from the slice stack and not on the MIP. 
This case was the only cancer from the dataset to be “missed” by 8/8 readers. This 
figure also demonstrates the appearance of movement artefact on subtracted 
images like FAST MRI. Movement artefact appears as adjacent black and white lines, 
together producing a “ghost-like” appearance (orange arrows). Movement artefact is 
likely to have contributed to the readers’ failure to perceive the lobular cancer. 
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Table 1: Clinical indication for the MRI scans of the dataset  
Table 2: Histology of cancers in dataset 
Table 3: Comparison of readers’ MRI classification against the true outcome 
 
Table 4: Accuracy of the FAST MRI readers against the true outcome   
 
Table 5: Individual Readers’ Results when MRI classifications 4 and 5 are considered as 
cancers 
 
 
